Overview

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo and Zyban for smoking cessation.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline